T. Rowe Price Associates’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $32.3M | Sell |
|
|||||
|
2023
Q3 | $62M | Buy |
|
|||||
|
2023
Q2 | $43.8M | Buy |
|
|||||
|
2023
Q1 | $438K | Buy |
|
|||||
|
2022
Q4 | $521K | Buy |
|
|||||
|
2022
Q3 | $482K | Buy |
|
|||||
|
2022
Q2 | $218K | Buy |
|
|||||
|
2022
Q1 | $224K | Buy |
|
|||||
|
2021
Q4 | $268K | Sell |
|
|||||
|
2021
Q3 | $497K | Buy |
|
|||||
|
2021
Q2 | $573K | Buy |
|
|||||
|
2021
Q1 | $679K | Buy |
|
|||||
|
2020
Q4 | $481K | Buy |
|
|||||
|
2020
Q3 | $45K | Hold |
|
|||||
|
2020
Q2 | $57K | Buy |
|
|||||
|
2020
Q1 | $39K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $2.44M | Buy |
|
|||||
|
2019
Q2 | $1.9M | Sell |
|
|||||
|
2019
Q1 | $6.61M | Buy |
|
|||||
|
2018
Q4 | $11.2M | Buy |
|
|||||
|
2018
Q3 | $21.5M | Sell |
|
|||||
|
2018
Q2 | $28.2M | Buy |
|
|||||
|
2018
Q1 | $23.2M | Buy |
|
|||||
|
2017
Q4 | $12.7M | Buy |
|
|||||
|
2017
Q3 | $7.15M | Buy |
|
|||||
|
2017
Q2 | $196K | Buy |
|
|||||
|
2017
Q1 | $107K | Hold |
|
|||||
|
2016
Q4 | $56K | Sell |
|
|||||
|
2016
Q3 | $199K | Hold |
|
|||||
|
2016
Q2 | $229K | Buy |
|
|||||
|
2016
Q1 | $362K | Hold |
|
|||||
|
2015
Q4 | $577K | Buy |
|
|||||
|
2015
Q3 | $263K | Sell |
|
|||||
|
2015
Q2 | $466K | Hold |
|
|||||
|
2015
Q1 | $290K | Sell |
|
|||||
|
2014
Q4 | $204K | Buy |
|
|||||
|
2014
Q3 | $320K | Hold |
|
|||||
|
2014
Q2 | $358K | Buy |
|
|||||
|
2014
Q1 | $318K | Hold |
|
|||||
|
2013
Q4 | $312K | Hold |
|
|||||
|
2013
Q3 | $363K | Buy |
|